The PERT Study - Training Factors of PERformance and Injuries (PERT)

November 5, 2026 updated by: University Hospital, Clermont-Ferrand

The goal of this observational study was to learn about injuries in professional football players and to find out whether daily monitoring data could help predict injuries. The study followed male players from the first team and the reserve team of a French first-division professional football club over one full competitive season.

The main questions were:

How often did injuries occur among players over the season? Which day-to-day changes in routinely monitored data were linked to the onset of a new injury (all injuries combined, intrinsic and extrinsic)? Were the results similar when looking only at intrinsic injuries?

Each day, the club's staff recorded each player's physical workload during training sessions and matches using tracking technology. Players also reported how they felt, including sleep, fatigue, mood, and pain. New injuries were recorded daily by the club's medical staff. Players took part through the club's usual daily monitoring, with no additional tests or visits.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

77

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France
        • CHU de Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Male football players from the first team and the reserve team of a French first-division professional football club, followed over one full competitive season.

Description

Inclusion Criteria:

  • Male football players belonging to the first team or the reserve team of the participating French first-division professional football club during the study season

Exclusion Criteria:

  • Fewer than 20 days of available monitoring data during the season

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: RETROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Professional football players

Male players from the first team and the reserve team of a French first-division professional football club, followed daily over one full competitive season through the club's routine monitoring of external workload, self-reported wellness and injury status.

No intervention was assigned. Data came from the club's usual daily monitoring: external workload measured by tracking technology during training sessions and matches, and self-reported sleep, fatigue, mood, pain and perceived intensity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury prevalence and occurrence of new injuries
Time Frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

Daily injury status (non-injured or injured) recorded by the club's medical staff, used to describe season-long injury prevalence.

Daily from June 26, 2023, to May 19, 2024 (47 weeks).
Player characteristics
Time Frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

Age (years), professional status (reserve team or professional), playing position (defender, midfielder or forward) and number of previous injuries (0, 1 or ≥2), examined as putative factors associated with injury occurrence.

Daily from June 26, 2023, to May 19, 2024 (47 weeks).
External workload
Time Frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

Measured by tracking technology during training sessions and matches: match exposure (yes or no), session duration (minutes), total distance covered (km), number of accelerations and decelerations per day, distance covered (m) and number of sprints per day at 80-90% and 90-100% of each player's individual maximal speed. Examined as putative factors associated with injury occurrence.

Daily from June 26, 2023, to May 19, 2024 (47 weeks).
Self-reported wellness and perceived exertion
Time Frame: Daily from June 26, 2023, to May 19, 2024 (47 weeks).

Sleep time (hours/day), sleep quality (1 = best to 7 = worst), mood (1 = best to 7 = worst), fatigue (1 = min to 7 = max), pain (1 = min to 7 = max) and perceived exertion (1 = min to 10 = max). Examined as putative factors associated with injury occurrence.

Daily from June 26, 2023, to May 19, 2024 (47 weeks).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Frédéric Dutheil, University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 5, 2026

First Posted (Actual)

November 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 9, 2026

Last Update Submitted That Met QC Criteria

November 5, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe